🇺🇸 CRL — Charles River Laboratories International, Inc.

Salud Compra
← Volver

Precio actual

326,29 USD

Máx. histórico

458,30

1867 días

Caída desde máximo

-28,80%

Rango 52 semanas

146,20 – 379,63

Variación hoy

-7,27%

Cierre anterior

351,87

Rango de hoy

325,35 – 354,99

Volumen hoy

1.728.177

Peor caída histórica

-78,23%

24/09/2021 → 11/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

35,93%

Información
Nombre completo
Charles River Laboratories International, Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Diagnostics & Research
Empleados
18.300
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
318,87 USD (puede no estar actualizado)
Primera cotización
23/06/2000
Precio actualizado
hace 20 horas
Sobre la empresa

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/02/2011 36,86 37,15 36,59 36,99 +0,30% 1,52% 812.800
03/02/2011 36,98 37,03 36,65 36,88 -0,19% 1,03% 1.024.900
02/02/2011 37,87 37,87 36,89 36,95 -2,27% 2,59% 1.108.600
01/02/2011 38,52 38,70 37,80 37,81 -1,41% 2,34% 1.120.000
31/01/2011 38,35 38,60 38,09 38,35 +0,10% 1,33% 721.400
28/01/2011 38,58 38,67 38,16 38,31 -0,49% 1,32% 676.100
27/01/2011 37,54 38,95 37,46 38,50 +2,53% 3,97% 1.154.300
26/01/2011 37,78 37,84 37,41 37,55 -0,45% 1,14% 833.000
25/01/2011 37,47 38,03 37,36 37,72 +0,11% 1,79% 941.100
24/01/2011 37,27 37,93 37,11 37,68 +1,24% 2,20% 1.098.600
21/01/2011 37,66 38,05 37,15 37,22 -0,72% 2,39% 759.400
20/01/2011 37,00 37,68 36,91 37,49 +1,21% 2,08% 744.700
19/01/2011 37,99 38,07 36,79 37,04 -2,78% 3,37% 962.600
18/01/2011 37,48 38,13 37,44 38,10 +1,63% 1,84% 839.300
14/01/2011 37,67 37,92 37,19 37,49 -0,42% 1,94% 865.900
13/01/2011 37,95 38,16 37,54 37,65 -0,89% 1,63% 1.013.100
12/01/2011 37,34 38,11 37,19 37,99 +2,26% 2,46% 1.296.400
11/01/2011 36,70 37,37 36,59 37,15 +1,48% 2,13% 976.400
10/01/2011 36,38 36,74 36,12 36,61 +0,08% 1,70% 682.600
07/01/2011 36,42 36,79 36,28 36,58 +0,66% 1,40% 1.054.900
06/01/2011 36,19 36,60 35,91 36,34 -0,85% 1,91% 1.405.000
05/01/2011 36,04 36,76 35,98 36,65 +1,24% 2,16% 1.060.200
04/01/2011 35,84 36,25 35,81 36,20 +1,00% 1,23% 1.192.400
03/01/2011 35,63 35,91 35,35 35,84 +0,84% 1,57% 1.111.800
31/12/2010 35,61 35,68 35,25 35,54 -0,50% 1,21% 735.500
30/12/2010 35,80 35,87 35,42 35,72 -0,25% 1,26% 615.700
29/12/2010 35,57 36,00 35,47 35,81 +0,70% 1,49% 806.800
28/12/2010 36,00 36,09 35,43 35,56 -1,19% 1,83% 718.900
27/12/2010 35,75 36,19 35,60 35,99 +0,81% 1,65% 709.100
23/12/2010 35,75 36,02 35,66 35,70 +0,28% 1,01% 558.200